Nabarun Dasgupta

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Venues

Drug safety

Pharmacoepidemiology and drug safety

American journal of epidemiology

JMIR public health and surveillance

Rocky Mountain Poison and Drug Center

University of North Carolina at Chapel Hill (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rocky Mountain Poison and Drug Center

United States

Research Scientist :: RADARS System

Education History

University of North Carolina at Chapel Hill

United States

PHD :: Epidemiology

Publications

Bethany L DiPrete, Nabarun Dasgupta, G Yeon Oh, Daniela C Moga, Svetla Slavova, Emily Slade, Chris Delcher, Brian W Pence, Shabbar I Ranapurwala
Abuse-deterrent formulations and opioid-related harms in North Carolina, 2010-2018. American journal of epidemiology (2024)
Jessica C Young, Kenneth Pack, Teresa B Gibson, Frank Yoon, Bethany L DiPrete, Virginia Pate, Debra E Irwin, Toska Cooper, Sarah Bloemers, Nabarun Dasgupta
Death ORACL: An Algorithm to Predict Death Using Insurance Claims Data. American journal of epidemiology (2024)
Bethany L DiPrete, G Yeon Oh, Daniela C Moga, Nabarun Dasgupta, Svetla Slavova, Emily Slade, Chris Delcher, Brian W Pence, Shabbar I Ranapurwala
Matching study design to prescribing intention: The prevalent new-user design for studying abuse-deterrent formulations of opioids. Pharmacoepidemiology and drug safety 33 (5) (2024)
Allison J Lazard, Sydney K Nicolla, Rhyan N Vereen, Shanetta M Pendleton, Marjory Charlot, Hung-Jui Tan, Dominic DiFranzo, Marlyn Pulido, Nabarun Dasgupta
Exposure and Reactions to Cancer Treatment Misinformation and Advice: Survey Study. JMIR cancer 9 (2023)
Dustin K Miracle, Svetla Slavova, John R Brown, Nabarun Dasgupta, Sarah Harris, Patricia R Freeman
Accuracy and validity of reported opioid prescription days' supply. Pharmacoepidemiology and drug safety 31 (12) (2022)
Nabarun Dasgupta
Countering Hesitancy and Misinformation on Side Effects to Complete the Course of COVID Vaccination. Journal of patient experience 8 (2021)
Nabarun Dasgupta, John R Brown, Maryalice Nocera, Allison Lazard, Svetla Slavova, Patricia R Freeman
Abuse-Deterrent Opioids: A Survey of Physician Beliefs, Behaviors, and Psychology. Pain and therapy (2021)
Nabarun Dasgupta
Commentary on Paljarvi et al: Can harder-to-crush oxycodone prevent overdose? Addiction (Abingdon, England) 116 (9) (2021)
Nabarun Dasgupta
Safety Consequences of Off-Label Drugs Used for COVID-19. Drug safety 44 (4) (2021)
Apostolos A Alexandridis, Nabarun Dasgupta, Christopher L Ringwalt, Wayne D Rosamond, Paul R Chelminski, Stephen W Marshall
Association between opioid analgesic therapy and initiation of buprenorphine management: An analysis of prescription drug monitoring program data. PloS one 15 (1) (2020)
Joshua Curtis Black, Karilynn M Rockhill, Alyssa Forber, Elise Amioka, K Patrick May, Colleen M Haynes, Nabarun Dasgupta, Richard C Dart
An Online Survey for Pharmacoepidemiological Investigation (Survey of Non-Medical Use of Prescription Drugs Program): Validation Study. Journal of medical Internet research 21 (10) (2019)
Roxanne Saucier, Daniel Wolfe, Nabarun Dasgupta
Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Drug safety 41 (10) (2019)
Jessica C Young, Jennifer L Lund, Nabarun Dasgupta, Michele Jonsson Funk
Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids. Pharmacoepidemiology and drug safety 28 (1) (2018)
Nabarun Dasgupta, Roxanne Saucier, Daniel Wolfe
Authors' Response to Silverman and Colleagues' Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence". Drug safety 41 (10) (2018)
Rikesh Patel, Maksim Belousov, Meghna Jani, Nabarun Dasgupta, Carly Winokur, Goran Nenadic, William G Dixon
Erratum: Author Correction: Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts. NPJ digital medicine 1 (2018)
Laurie S Anderson, Heidi G Bell, Michael Gilbert, Julie E Davidson, Christina Winter, Monica J Barratt, Beta Win, Jeffery L Painter, Christopher Menone, Jonathan Sayegh, Nabarun Dasgupta
Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis. JMIR public health and surveillance 3 (1) (2017)
Carrie E Pierce, Khaled Bouri, Carol Pamer, Scott Proestel, Harold W Rodriguez, Hoa Van Le, Clark C Freifeld, John S Brownstein, Mark Walderhaug, I Ralph Edwards, Nabarun Dasgupta
Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. Drug safety 40 (4) (2017)

Nabarun Dasgupta

Publication Activity (10 Years)

Top Topics

Top Venues